The tuberculin skin test increases the responses measured by T cell interferon-gamma release assays

Scandinavian Journal of Immunology

Volumn 67, Issue 6, 2008, Pages 610-617

  Vilaplana, C ^a,d   Ruiz Manzano, J ^b   Gil, O ^a,d   Cuchillo, F ^a,d   Montane E ^b   Singh, M ^c   Spallek, R ^c   Ausina, V ^a,d   Cardona, P J ^a,d,e  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^c LIONEX DIAGNOSTICS AND THERAPEUTICS GMBH   (Germany)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

^e FUNDACIÓ INSTITUT D INVESTIGACIÓ EN CIÈNCIES DE LA SALUT GERMANS TRIAS I PUJOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; ISONIAZID; MYCOBACTERIUM ANTIGEN; MYCOBACTERIUM TUBERCULOSIS RUTI VACCINE; RT 23;

ADULT; ARTICLE; CLINICAL TRIAL; CROSS REACTION; DIAGNOSTIC ACCURACY; DOSE CALCULATION; ENZYME LINKED IMMUNOSPOT ASSAY; HUMAN; HUMAN EXPERIMENT; IMMUNE RESPONSE; IMMUNOASSAY; MYCOBACTERIUM TUBERCULOSIS; NORMAL HUMAN; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; T CELL INTERFERON GAMMA RELEASE ASSAY; TUBERCULIN TEST; TUBERCULOSIS; VACCINE PRODUCTION;

ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INTERFERON TYPE II; LEUKOCYTES, MONONUCLEAR; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; SENSITIVITY AND SPECIFICITY; T-LYMPHOCYTES; TUBERCULIN; TUBERCULIN TEST; TUBERCULOSIS;

EID: 43549103054     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2008.02103.x     Document Type: Article

References (35)

1. World Health Organization Global Tuberculosis Control: Surveillance, Planning, Financing. Geneva : WHO report, 2006.
2. Comstock GW. How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults? Int J Tuberc Lung Dis 1999 3 : 847 50.
3. Institute of Medicine (U.S.). Committee on the Elimination of Tuberculosis in the United States. Ending Neglect. The Elimination of Tuberculosis in the United States. Washington DC : National Academy Press, 2000.
4. Pai M, Riley LW, Colford JM Jr. Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 2004 4 : 761 76.
5. Rieder HL Epidemiologic Basis of Tuberculosis Control. Paris : International Union Against Tuberculosis and Lund Disease, 1999.
6. Grupo de Trabajo de los Talleres de 2001 y 2002 de la Unidad de Investigación en Tuberculosis de Barcelona. Prevention and control of imported tuberculosis. Med Clin (Barc) 2003 121 : 549 57.
7. American Thoracic Society and the Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000 161 : S221 47.
8. Haslov K, Closs O, Moller S, Bentzon MW. Studies on the development of tuberculin sensitivity in immunized guinea pigs with demonstration of a close relationship between results of skin tests and the lymphocyte transformation technique. Int Arch Allergy Appl Immunol 1984 73 : 114 22.
9. Farhat M, Greenaway C, Pai M, Menzies D. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis 2006 10 : 1192 204.
10. Rothel JS, Andersen P. Diagnosis of latent Mycobacterium tuberculosis infection: is the demise of the Mantoux test imminent? Expert Rev Anti Infect Ther 2005 3 : 981 93.
11. National Institute for Health and Clinical Excellence. Clinical Guideline 33. Tuberculosis: Clinical Diagnosis and Management of Tuberculosis, and Measures for its Prevention and Control. URL: http://www.nice.org.uk/page.aspx? o=CG033NICEguideline. Volume 2006. London, NICE.
12. Gruppi di Studio Infezioni e Tubercolosi dell'Associazione Italiana Pneumologi Ospedalieri (AIPO) e della Società Italiana di Medicina Respiratoria (SIMeR). Documento sull'utilizzo dei nuovi test immunologici per la diagnosi di infezione tubercolare latente. 2006 http://www.simernet.it/ Download/LG_SIMeR_AIPO_LTBI9maggio2006.doc.
13. Cardona PJ. RUTI: a new chance to shorten the treatment of latent tuberculosis infection. Tuberculosis (Edinb) 2006 86 : 273 89.
14. Cardona PJ. New insights on the nature of latent tuberculosis infection and its treatment. Inflammation & Allergy Drug Targets 2007 6 : 27 39.
15. Cardona PJ, Amat I, Gordillo S et al. Immunotherapy with fragmented Mycobacterium tuberculosis cells increases the effectiveness of chemotherapy against a chronical infection in a murine model of tuberculosis. Vaccine 2005 23 : 1393 8.
16. Ibanga HB, Brookes RH, Hill PC et al. Early clinical trials with a new tuberculosis vaccine, MVA85A, in tuberculosis-endemic countries: issues in study design. Lancet Infect Dis 2006 6 : 522 8.
17. McShane H, Pathan AA, Sander CR, Goonetilleke NP, Fletcher HA, Hill AV. Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials. Tuberculosis (Edinb) 2005 85 : 47 52.
18. Mawa PA, Pickering JM, Miiro G et al. The effect of tuberculin skin testing on viral load and anti-mycobacterial immune responses in HIV-1-infected Ugandan adults. Int J Tuberc Lung Dis 2004 8 : 586 92.
19. Thom ML, Hope JC, McAulay M et al. The effect of tuberculin testing on the development of cell-mediated immune responses during Mycobacterium bovis infection. Vet Immunol Immunopathol 2006 114 : 25 36.
20. Arend S, Thijsen S, Leyten E et al. Comparison of two interferon-gamma assays and tuberculin skin test for tracing TB contacts. Am J Respir Crit Care Med 2007 175 : 618 27.
21. Franken WP, Timmermans JF, Prins C et al. Comparison of Mantoux and QuantiFERON TB Gold tests for diagnosis of latent tuberculosis infection in Army personnel. Clin Vaccine Immunol 2007 14 : 477 80.
22. Gooding S, Chowdhury O, Hinks T et al. Impact of a T cell-based blood test for tuberculosis infection on clinical decision making in routine practice. J Infect 2006 doi:
23. Kobashi Y, Obase Y, Fukuda M, Yoshida K, Miyashita N, Oka M. Clinical reevaluation of the QuantiFERON TB-2G test as a diagnostic method for differentiating active tuberculosis from nontuberculous mycobacteriosis. Clin Infect Dis 2006 43 : 1540 6.
24. Pai M, Gokhale K, Joshi R et al. Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood interferon-γ assay with tuberculin skin testing. JAMA 2005 293 : 2746 55.
25. Richeldi L, Ewer K, Losi M et al. T-cell-based diagnosis of neonatal multidrug-resistant latent tuberculosis infection. Pediatrics 2007 119 : e1 5.
26. Shams H, Weis SE, Klucar P et al. Enzyme-linked immunospot and tuberculin skin testing to detect latent tuberculosis infection. Am J Respir Crit Care Med 2005 172 : 1161 8.
27. Dewan PK, Grinsdale J, Kawamura LM. Low sensitivity of a whole-blood interferon-gamma release assay for detection of active tuberculosis. Clin Infect Dis 2007 44 : 69 73.
28. Dogra S, Narang P, Mendiratta DK et al. Comparison of a whole blood interferon-γ assay with tuberculin skin testing for the detection of tuberculosis infection in hospitalized children in rural India. J.Infect 2007 54 : 267 76.
29. Pai M, Dogra S, Narang PJ. Interferon-gamma release assays in children-no better than tuberculin skin testing: Response to Ranganathan S et al. J Infect 2007 54 : 414 5.
30. Pai M, Joshi R, Dogra S et al. Serial testing of health care workers for tuberculosis using interferon-assay. Am J Respir Crit Care Med 2006 174 : 349 55.
31. Centers for Disease Control and Prevention. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings. MMWR 2005 54 : 1 141.
32. Mazurek GH, Jereb J, Lobue P, Iademarco MF, Metchock B, Vernon A. Division of tuberculosis elimination, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection. United States. MMWR 2005 54 : 49 55.
33. ®-TB Gold to investigate tuberculosis contacts in a high school. Respirology 2007 12 : 88 92.
34. Leyten EM, Prins C, Bossink AW et al. Effect of tuberculin skin testing on a Mycobacterium tuberculosis-specific IFN-γ assay. Eur Respir 2007 29 : 1212 6.
35. Richeldi L, Ewer K, Losi M, Roversi P, Fabbri LM, Lalvani A. Repeated tuberculin testing does not induce false positive ELISPOT results. Thorax 2006 61 : 180.